Skip to main content

Claire Pomeroy

Equibles does not estimate personal net worth.

Get an email with a short summary when Embecta Corp. publishes a filing, an earnings call transcript or a press release.

Get EMBC alerts

About Claire Pomeroy

Claire Pomeroy is recorded as Board Member at Embecta Corp. (EMBC) since January 1, 2022, Board Member at Becton Dickinson & Co (BDX) since July 12, 2021 and Board Member at Haemonetics Corp (HAE) since January 1, 2019. The newest filing on record that lists Claire Pomeroy as Board Member at Embecta Corp. (EMBC) is dated December 18, 2025. The newest filing on record that lists Claire Pomeroy as Board Member at Haemonetics Corp (HAE) is dated June 9, 2026. Embecta Corp. reported in an 8-K filed November 17, 2025 that Claire Pomeroy was appointed Lead Independent Director. Becton Dickinson & Co is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Embecta Corp. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Becton Dickinson & Co includes David F. Melcher (Chairman), Thomas E. Polen (Chairman and Board Member), Patrick K. Kaltenbach (CTO) and 7 others.

“The Company's independent directors expect to appoint Devdatt (Dev) Kurdikar as the Chairman of the Board and Dr. Claire Pomeroy as the Board's Lead Independent Director, each effective upon LTG Melcher's departure from the Board at the Company's 2026 annual meeting of stockholders.”
Embecta Corp. Form 8-K, filed November 17, 2025 · Read the filing

Affiliation history

Company network

Current role

Medical Instruments & Supplies · Healthcare

Board Member

2014-01-01–present

Current role

Medical Instruments & Supplies · Healthcare

Board Member

2022-01-01–present

Current role

Medical Devices · Healthcare

Board Member

2019-01-01–present

Leadership on record at Becton Dickinson & Co

Leadership on record at Embecta Corp.

Leadership on record at Haemonetics Corp

Recent activity